Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
Double board-certified facial plastic surgeon expands Restylane Contour offerings at Rubinstein Plastic Surgery Center in ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
1mon
Galderma Receives U.S. FDA Approval for Restylane Contour for the Correction of Temple Hollowing
Food and Drug Administration (FDA) has approved Restylane Contour* for the correction of temple hollowing, expanding its use beyond cheek augmentation and midface contour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results